IL6 and autoimmune disease: As a result, using PSL in combination with 114 increased the concentration of Th2 cytokines, such as IL-6, suggesting that this combination could potentially restructure Th1 and Th2 composition (toward Th2 dominant) and improve the clinical state of Th1-mediated autoimmune diseases.